Alx Oncology Holdings Cash Flow Statement (2019-2026) | ALXO

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-16.27M	-24.57M	2.11M	-24.52M	-32.91M	-35.31M	-30.64M	-30.28M	-34.48M	-50.99M	91.07M	-35.57M	-39.39M	-30.71M	-29.16M	-30.74M	-25.95M	-22.14M	-22.83M	-18.11M
Share-based Compensation (Quarter)	2.24M	4.19M	5.69M	5.50M	5.84M	6.21M	6.29M	6.35M	6.24M	6.96M	6.72M	7.03M	7.25M	6.95M	5.86M	5.22M	2.14M	2.52M	2.71M	2.51M
Gains from Sales and Divestitures (Quarter)				0.00M	0.00M	0.00M	0.05M				0.29M				0.37M				0.28M
Gains from Investment Securities (Quarter)		-1.64M	0.10M	0.10M	0.50M	0.90M	0.11M	0.11M	0.11M	0.97M	-0.80M	0.17M	0.22M	0.36M	1.85M	0.31M	0.24M	0.16M	0.23M	0.31M
Asset Writedowns and Impairment (Quarter)																	3.20M	0.03M
Non-cash Items (Quarter)			49.74M				19.87M				59.90M				0.41M				6.09M
Cash from Operations (Quarter)	-20.62M	-24.86M	-17.49M	-20.67M	-17.00M	-30.88M	-20.67M	-27.82M	-31.71M	-31.16M	-39.68M	-37.92M	-26.57M	-25.38M	-32.05M	-24.66M	-23.41M	-17.09M	-18.98M	-18.65M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)				-0.11M	0.00M	0.36M	0.68M	1.11M	1.65M	1.84M	1.88M	1.55M	1.32M	1.05M	0.74M	0.53M	0.31M	0.22M	0.19M	0.20M
Amortization of Deferred Charges (Quarter)								0.06M	0.06M	0.06M	0.06M	0.06M	0.07M	0.07M	0.07M	0.07M	0.07M	0.07M	0.07M	0.07M
Depreciation & Amortization (CF) (Quarter)	0.01M	0.01M	0.03M	0.06M	0.08M	0.10M	0.10M	0.21M	0.21M	0.21M	0.21M	0.21M	0.22M	0.22M	0.21M	0.21M	0.19M	0.15M	0.15M	0.15M
Change in Working Capital
Change in Account Payables (Quarter)	-1.54M	-2.18M	-0.33M	1.55M	3.56M	-3.06M	2.45M	1.77M	-5.71M	8.89M	-4.48M	-2.33M	1.88M	-0.19M	-3.39M	-0.56M	0.96M	1.68M	-1.67M	-1.21M
Change in Accured Expenses (Quarter)	0.62M	1.12M	0.97M	-1.30M	4.07M	3.65M	0.61M	-5.55M	3.75M	8.29M	4.73M	-1.08M	4.74M	-5.39M	-10.89M	-0.10M	-1.92M	6.17M	-2.15M	-3.01M
Other Working Capital Changes (Quarter)	8.75M	1.61M	-11.35M	0.32M	-0.89M	3.19M	-3.59M	-1.18M	3.14M	2.35M	-6.66M	4.50M	1.56M	-8.24M	0.10M	-1.89M	1.24M	-0.85M	2.19M	-0.42M
Investing Activities
Capital Expenditures (Quarter)		0.40M	0.26M	0.59M	0.26M	0.19M	0.39M	0.69M	1.74M	-1.30M	0.15M	0.15M	0.09M	0.15M	0.06M	0.06M	0.05M	0.06M	0.05M	0.05M
Change in Acquisitions & Divestments (Quarter)						50.50M	72.30M	115.19M	54.48M	64.40M	58.49M	57.91M	63.96M	34.55M	37.69M	43.48M	47.77M	25.89M	17.26M	19.50M
Cash from Investing Activities (Quarter)		-0.40M	-4.52M	-183.92M	-76.13M	13.70M	10.94M	42.30M	6.21M	12.81M	-16.67M	26.47M	0.91M	25.69M	33.18M	27.64M	22.32M	21.39M	11.23M	-105.04M
Financing Activities
Other financing activities (Quarter)	0.46M	0.53M	0.53M	0.18M	0.15M	0.01M	0.22M		0.11M			0.24M	0.86M	0.53M			-0.00M	0.00M		0.67M
Cash from Financing Activities (Quarter)	0.73M	0.44M	0.52M	0.08M	0.42M	-0.14M	9.49M	-0.11M	0.34M	-0.11M	59.17M	3.09M	27.15M	0.25M	0.33M	0.07M	-0.22M	-0.16M	0.68M	139.59M
Additional items
Change in Cash (Quarter)	-19.89M	-24.82M	-21.48M	-204.51M	-92.71M	-17.32M	-0.23M	14.37M	-25.16M	-18.45M	2.82M	-8.37M	1.49M	0.57M	1.47M	3.05M	-1.31M	4.14M	-7.07M	15.91M
Free Cash Flow (Quarter)	-20.62M	-25.25M	-17.75M	-21.26M	-17.25M	-31.07M	-21.06M	-28.51M	-33.45M	-29.86M	-39.83M	-38.07M	-26.66M	-25.52M	-32.11M	-24.72M	-23.45M	-17.15M	-19.03M	-18.70M
Net Cash Flow (Quarter)	-19.89M	-24.82M	-21.48M	-204.51M	-92.71M	-17.32M	-0.23M	14.37M	-25.16M	-18.45M	2.82M	-8.37M	1.49M	0.57M	1.47M	3.05M	-1.31M	4.14M	-7.07M	15.91M

Research Tools

Developers

Alx Oncology Holdings Cash Flow Statement (2019-2026) | ALXO

Research Tools

Developers

Alx Oncology Holdings Cash Flow Statement (2019-2026) | ALXO

Create an account

Sign In

Reset Password